Two Sigma Investments
EDSA icon

Two Sigma Investments’s Edesa Biotech EDSA Stock Holding History

Two Sigma Investments’s Portfolio EDSA Stock Details EDSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,653
Closed -$9.38K – 3013
2023
Q2 		$9.38K Sell
1,653
-2,162
-57% -$14.4K ﹤0.01% 2946
2023
Q1 		$24.4K Buy
+3,815
New +$39.8K ﹤0.01% 2833
2022
Q2 		– Sell
-1,587
Closed -$33K – 2621
2022
Q1 		$33K Sell
1,587
-215
-12% -$5.96K ﹤0.01% 2511
2021
Q4 		$71K Buy
+1,802
New +$86.2K ﹤0.01% 4110
2021
Q1 		– Sell
-3,213
Closed -$96K – 3915
2020
Q4 		$96K Buy
+3,213
New +$131K ﹤0.01% 3215

Other funds holding EDSA

VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Two Sigma Investments's EDSA Position: Q3 2023 in Review

Two Sigma Investments sold out of Edesa Biotech (EDSA) in Q3 2023, closing a stake of 1,653 shares — an estimated $9.38K sold.

Two Sigma Investments first reported a position in EDSA in Q4 2020 and held it in 5 quarters. The position peaked at $96K in Q4 2020. 20 funds tracked by Wall St. Rank hold EDSA as of Q3 2023.

  • Two Sigma Investments reported no remaining Edesa Biotech position as of Q3 2023 after selling out during the quarter.
  • Two Sigma Investments sold 1,653 Edesa Biotech shares in Q3 2023, an estimated $9.38K.
  • Two Sigma Investments first reported a position in Edesa Biotech in Q4 2020 and held it in 5 quarters.
  • Two Sigma Investments's Edesa Biotech position peaked at $96K in Q4 2020.
  • 20 funds tracked by Wall St. Rank held Edesa Biotech as of Q3 2023.

Based on Two Sigma Investments's 13F filing for Q3 2023, filed 14 Nov 2023.